It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...

Back-up Singers: See the sunlight! Johnny P Lant: …Shining on my leaves. Then they turn it into food, helping me to feed.